v3.25.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities    
Net loss $ (1,986,153) $ (8,967,515)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 197,355 182,664
Valuation adjustments for excess or obsolete inventory 7,500
Stock-based compensation 906,048 1,004,105
Amortization of deferred offering costs 192,647
Non-cash lease expense 83,187 86,611
Fair value change in warrant liability (1,099,421)
Debt and equity facility termination costs reclassed to financing activities 141,416
Change in assets and liabilities:    
Accounts receivable 176,636 (410,551)
Inventory 729,952 (66,746)
Prepaid expenses (16,902) 2,269
Accounts payable (286,960) 44,787
Accrued expenses, operating leases and other liabilities (356,905) (220,581)
Net cash used in operating activities (1,311,600) (8,344,957)
Investing activities    
Purchase of property and equipment (71,135) (83,292)
Net cash used in investing activities (71,135) (83,292)
Financing activities    
Proceeds from issuance of common stock attributed to equity financings 9,614,037 5,033,906
Issuance costs related equity financings (1,231,873) (236,599)
Financing costs in connection with debt facility (297,942)
Share repurchases for the payment of employee taxes (121,846) (71,574)
Net cash provided by financing activities 7,962,376 4,725,733
Net increase (decrease) in cash and cash equivalents 6,579,641 (3,702,516)
Cash and cash equivalents at beginning of period 1,460,042 5,322,493
Cash and cash equivalents at end of period 8,039,683 1,619,977
Supplemental non-cash financing and investing transactions:    
Modification of right-of-use asset and associated lease liability 111,898 199,385
Purchased property and equipment in accounts payable $ 7,228 $ 34,000